Sara Zborovski practises regulatory and commercial law for companies regulated by Health Canada. Ms. Zborovski assists clients in navigating the regulatory landscape implemented by the Food and Drugs Act, the Cannabis Act and other legislation and associated regulations overseen by Health Canada and the intersection of these with commercial and intellectual property laws. Ms. Zborovski counsels pharmaceutical, cannabis, food and beverage, natural health product, medical device, cosmetic and tobacco companies on market access, authorizations and licensing, product safety and advertising/marketing these products in Canada.
Ms. Zborovski assists with product licence strategies, market access strategies (including assistance with the Common Drug Review and provincial and private formulary listings) and establishment licensing and GMP/GPP programs. On the compliance side, Ms. Zborovski assists clients in developing SOPs and compliance policies, ensuring compliant packaging and labelling (including label reviews), and provides strategic advice on advertising and marketing programs (including assistance with pre-clearance agencies and representing companies in disputes before the Pharmaceutical Advertising Advisory Board and Advertising Standards Canada). She also advises clients on federal and provincial privacy laws, particularly as these relate to healthcare, and federal and provincial access to information and freedom of information matters.
Ms. Zborovski also works with clients in all industries on matters relating to product safety, including crisis management, advocacy before the inspectorate, and product recalls.
Ms. Zborovski has particular experience with the pharmaceutical, cannabis, and food and beverage industries. She has developed a deep understanding of the regulatory and business realities within which these industries operate through her involvement with industry trade associations, thought leadership, and regular communication with various branches of Health Canada.